FDA label
What is edaravone used for?
The FDA-approved uses of edaravone, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted edaravone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Edaravone, injection, solution
Indications and Usage, quoted from the label by Piramal Critical Care Inc. (ANDA216199). Cross-references to other label sections are left out.
Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Source: DailyMed label, set id 19862ae9-d6e1-70e6-e063-6394a90ae749, version 3, effective October 7, 2025. NDC 66794-259, one of 3 listings for this product.
Questions
What is edaravone used for?
The FDA label says: “Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.